HomeTOP STORIESKura Oncology outlines $315M near-term milestones as ziftomenib nears FDA decision and... Kura Oncology outlines $315M near-term milestones as ziftomenib nears FDA decision and frontline trials expand By rogerjudd November 4, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleMarathon Petroleum plunges after Q3 earnings miss; sees continued high turnaround costsNext articleElon Musk Sees Robots And Robotaxis As Tesla’s Future. Can He Deliver? latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
